DJP vs. BOUT ETF Comparison
Comparison of iPath Dow Jones UBS Commodity Index Total Return ETN (DJP) to Innovator IBD Breakout Opportunities ETF (BOUT)
DJP
iPath Dow Jones UBS Commodity Index Total Return ETN
DJP Description
The investment seeks replicate, net of expenses, the Dow Jones-UBS Commodity Total Return index. The index also reflects the returns that are potentially available through an unleveraged investment in the futures contracts on physical commodities comprising the index plus the rate of interest that could be earned on cash collateral invested in specified Treasury Bills.
Grade (RS Rating)
Last Trade
$32.01
Average Daily Volume
60,392
Number of Holdings
*
1
* may have additional holdings in another (foreign) market
BOUT
Innovator IBD Breakout Opportunities ETF
BOUT Description
The investment seeks to track, before fees and expenses, the performance of the IBD® Breakout Stocks Index (the "index"). The fund will normally invest at least 80% of its net assets (including investment borrowings) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to "break out," or experience a period of sustained price growth beyond the stock's recent "resistance level," with consideration for various market conditions. The fund is non-diversified. BOUT uses technical analysis to find stocks that are likely to breakout. The funds index relies on an algorithm that establishes a base price (a recent high) for each eligible security. The index then follows the trend for each stock. Selected stocks are ranked by a combination of relative strength and fundamental factors, and then weighted in fixed tiers according to this ranking. In addition, BOUT will move 50% of its portfolio into T-bills based on market signals: a rapid increase in either margin debt or overall stock prices, combined with slowing reversing momentum in the S&P 500. The T-bill position will remain in place until the S&P 500 falls by 50% or show indications of rising momentum. BOUT is rebalanced and reconstituted weekly after the close on Friday. The frequent rebalance schedule means the fund will be highly responsive to the technical factors that drive its strategy, but could also experience high turnover.Grade (RS Rating)
Last Trade
$40.14
Average Daily Volume
2,990
Number of Holdings
*
44
* may have additional holdings in another (foreign) market
Performance
Period | DJP | BOUT |
---|---|---|
30 Days | -0.81% | 7.95% |
60 Days | 1.59% | 9.94% |
90 Days | 4.22% | 9.81% |
12 Months | 1.52% | 32.83% |
0 Overlapping Holdings
Symbol | Grade | Weight in DJP | Weight in BOUT | Overlap |
---|
DJP Overweight 1 Positions Relative to BOUT
Symbol | Grade | Weight | |
---|---|---|---|
ERII | F | 39.79% |
DJP Underweight 44 Positions Relative to BOUT
Symbol | Grade | Weight | |
---|---|---|---|
PACS | F | -4.48% | |
MS | A | -4.47% | |
LBRDK | C | -4.44% | |
NEM | D | -4.42% | |
VIK | B | -4.39% | |
EXPE | B | -4.28% | |
EQIX | A | -4.25% | |
AHR | A | -4.24% | |
IDCC | B | -4.01% | |
ETN | A | -3.82% | |
SPGI | C | -3.81% | |
EQH | C | -3.78% | |
CRM | B | -3.73% | |
BAH | F | -3.73% | |
DVA | C | -3.71% | |
PGR | A | -3.63% | |
CRDO | B | -2.87% | |
VRNS | D | -2.61% | |
ULS | B | -2.59% | |
IR | B | -2.49% | |
DT | D | -2.49% | |
NMIH | C | -2.44% | |
ONON | A | -2.35% | |
COLL | F | -2.23% | |
TSM | B | -1.31% | |
TBBK | C | -1.28% | |
NOW | A | -1.27% | |
CDNA | D | -1.24% | |
SCCO | F | -1.22% | |
SN | D | -1.2% | |
TCOM | B | -1.14% | |
BEKE | D | -1.06% | |
ROAD | B | -0.45% | |
AXON | A | -0.43% | |
TPH | D | -0.42% | |
IBKR | A | -0.42% | |
CWAN | B | -0.42% | |
AVGO | D | -0.42% | |
ALKT | B | -0.42% | |
GMED | A | -0.41% | |
CORT | B | -0.41% | |
ACGL | C | -0.4% | |
PLMR | A | -0.39% | |
JD | D | -0.38% |
DJP: Top Represented Industries & Keywords
BOUT: Top Represented Industries & Keywords
Industries:
Software - Application
Capital Markets
Insurance - Property & Casualty
Insurance - Diversified
Leisure
Semiconductors
Aerospace & Defense
Apparel Retail
Banks - Regional - US
Biotechnology
Business Services
Communication Equipment
Copper
Diagnostics & Research
Diversified Industrials
Drug Manufacturers - Specialty & Generic
Engineering & Construction
Furnishings, Fixtures & Appliances
Gold
Medical Care